Rigel Pharmaceuticals reported $-12965000 in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Agenus AGEN:US $ -44.56M 9.1M
Amgen AMGN:US $ 2176M 324M
Anika Therapeutics ANIK:US $ -3.38M 0.17M
Applied Genetic Technologies AGTC:US $ -13.58M 4.86M
Arrowhead Research ARWR:US $ -72909000 114.46M
AstraZeneca AZN:LN 44.27B 22.58B
Astrazeneca AZN:US 539M 339M
Biomarin Pharmaceutical BMRN:US $ 39.15M 98.18M
Bristol Myers Squibb BMY:US $ 2590M 37M
Celldex Therapeutics CLDX:US $ -36.4M 13.14M
Chemocentryx CCXI:US $ -31.57M 6.66M
Daiichi Sankyo 4568:JP Y 34382M 85129M
Eli Lilly And LLY:US $ 1210.1M 1194.2M
Halozyme Therapeutics HALO:US $ 34.06M 41.61M
Heron Therapeutics HRTX:US $ -49.5M 13.42M
Immunogen IMGN:US $ -61.05M 38.2M
Intrexon XON:US $ -24.16M 6.27M
Karyopharm Therapeutics KPTI:US $ -42908000 8.32M
Ligand Pharmaceuticals LGND:US $ -0.47M 7.34M
Macrogenics MGNX:US $ -41808000 24.83M
Neurocrine Biosciences NBIX:US $ -15.3M 18.4M
Pfizer PFE:US $ 12102M 2229M
Regeneron Pharmaceuticals REGN:US $ 1109.9M 148.6M
Rigel Pharmaceuticals RIGL:US $ -12.96M 13.3M
Sangamo Biosciences SGMO:US $ -45.73M 0.47M
Ultragenyx Pharmaceutical RARE:US $ -141.59M 4.96M
Veracyte VCYT:US $ -10.73M 4.51M